Armed with $3.25 million CAD in seed funding, Montréal-based healthtech start-up Ditch Labs wants to help smokers wean themselves off nicotine with its dual hardware-software solution. Ditch Labs’ solution consists of a medical nicotine vaporizer that facilitates controlled delivery and a complementary app that provides personalized support, progress tracking, and behavioural interventions. With this combo, the startup aims to address the physiological and psychological impacts of nicotine addiction simultaneously.
Ditch Labs presented at the OBIO® Investment Summit.